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ABSTRACT
Introduction: Commercially available chlorhexidine (CHX) 
formulations differ in their CHX concentrations (0.2% and 
0.12%) as well as in various additives including alcohol, 
antimicrobials such as cetylpyridinium chloride and anti-
discolouration chemicals such as ascorbic acid and so-
dium metabisulphite. 
Aims and objectives: To compare in vitro the antimicro-
bial efficacies of three different CHX preparations (Cor-
sodyl®, Curasept® and GUM® Paroex®) using 0.2% and 
0.12% CHX concentrations as controls 
Methods: A disk diffusion test was performed using 
pure cultures of the organisms Streptococcus mutans 
and Candida albicans, and mixed cultures (facultative and 
strict anaerobes) prepared from oral rinse samples of 14 
study participants. The means and standard deviations of 
the diameters of inhibition zones were calculated.
Results: A statistically significant difference (p value = 
0.0001) was found only in Candida albicans cultures be-
tween the mean inhibition zones of the CHX preparation 
disks. Pure CHX preparations and Corsodyl® showed higher 
antifungal efficacy than Curasept® and GUM® Paroex
Conclusion: Both CHX preparations (0.12% and 0.2%) 
and the 0.2% CHX preparation containing alcohol 
(Corsodyl®) have more potent antifungal properties against 
C. albicans than alcohol-free 0.12% CHX preparations 
such as Curasept® and GUM® Paroex®. 
INTRODUCTION
Chlorhexidine (CHX) is the most commonly used antimi-
crobial agent in dentistry. Because of its wide range of 
antimicrobial activity, it has been incorporated as an an-
tiplaque agent into several oral hygiene products such as 
dentifrices and mouthrinses. Based on its clinical efficacy, 
CHX is currently regarded as the “gold standard” for eval-
uating new chemical plaque control agents.1
 
Most commercially available mouthrinses, including some 
CHX based mouthrinses, contain alcohol, with concentra-
tions being as high as 14-15%.2 However, the addition of 
alcohol is controversial because of its potential carcino-
genic and tissue irritating properties. Several manufactur-
ers have therefore developed alcohol-free CHX based oral 
hygiene products as alternatives.2 Limited data exists with 
regards to the antibacterial efficacy of these products, 
with studies indicating that alcohol-based CHX formula-
tions are more effective than alcohol-free formulations.2 
Commercially available CHX formulations differ in their 
concentrations as well as in the component additives. 
Most CHX mouthrinses are prepared in concentrations of 
0.2% or 0.12%. In this study, the antimicrobial efficacy of 
three locally available CHX based mouthrinses i.e. Cor-
sodyl Mouthwash® 0.2% CHX (GlaxoSmithKline, Epping, 
South Africa), Curasept ADS® 220 Oral rinse 0.2 % CHX 
(Curaden AG, Krein, Switzerland) and GUM® Paroex® 
0.12% CHX (Sunstar Europe S.A., Etoy, Switzerland) were 
evaluated for their antimicrobial efficacy.
 
MATERIALS AND METHODS
Study design 
An in vitro analytical comparative study was carried out 
to evaluate three commercially available CHX-based 
mouthrinses. 
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Study sample
Oral rinse samples were collected from 14 healthy staff 
members at the University of the Western Cape Dental 
Faculty (UWC) who met the inclusion criteria (Table 1).
Specimen preparation and data collection 
Each subject was supplied with 10 ml of sterile saline in a 
universal container and instructed to rinse his/her mouth 
in the presence of the researcher for 60 seconds and then 
to return the mouth rinse to the container.6 100µl of the 
rinse was inoculated onto previously prepared Brain Heart 
Infusion agar plates (BHI), by spreading the sample over 
the agar surface with a sterile glass rod. For each oral 
rinse sample, two plates were prepared, one for faculta-
tive anaerobic cultures, and the other for strictly anaerobic 
cultures. The latter was done to culture Gram negative 
anaerobic bacteria, such as Veillonella and Fusobacteria.7 
The anaerobic conditions were created inside an anaero-
bic jar utilizing an Oxoid® Gas generating kit (UK), with 
palladium as a catalyst. A colour indicator was used to 
signal the transformation to an anaerobic environment. 
For the facultative anaerobic cultures, an anaerobic incu-
bator was used. The incubation period for both culture 
types was 24 hours. 
Preparation of pure cultures
Pure cultures of S. mutans NCTC 25175 and C. albicans 
NCTC 36801 were selected, as these microorganisms are 
known aetiological factors for dental caries and candidiasis 
respectively. These were cultured in the laboratory for 24 
hours. Thereafter, a separate inoculum from each culture 
was prepared. This was done by selecting an appropriate 
culture and preparing a suspension thereof in saline using 
the direct colony suspension method.
The two suspensions (S. mutans and C. albicans) were 
standardized to 0.5 McFarland standard (corresponding 
approximately to 1.5 X 108 CFU/ml). The McFarland scale 
is used for measuring bacterial densities in suspensions. 
There was no need to standardize the turbidity of the oral 
rinse samples since its natural turbidity closely approxi-
mated that of the 0.5 McFarland standard.
100µl of each suspension was inoculated onto 14 stand-
ard BHI plates within a quarter of an hour of the suspen-
sion preparation. Sterile glass-rods were used to spread 
the suspension evenly over the surface of the plate. This 
produced an acceptable distribution of the bacterial colo-
nies on the surface of the 28 agar plates. 
The CHX preparations
Three commercially available mouthrinses, representing 
the most prevalent CHX-based rinses in South African 
markets, were purchased from local stores, whilst the 
controls - (only CHX formulations) were prepared by the 
Institute of Oral and Dental Research at the Faculty of 
Dentistry, University of the Western Cape (Table 2).
 
The control CHX formulations (referred to hereunder as 
“only CHX”) were water based and alcohol free solutions 
that were prepared in two different concentrations i.e. 
0.2% & 0.12%. The only CHX 0.2% acted as a control for 
Corsodyl® and Curasept ADS® 220 (both containing CHX 
0.2% concentration), whilst only CHX 0.12% acted as the 
control for GUM® Paroex® which contained CHX 0.12%.
Disk Diffusion Test to measure inhibition zones:
The 56 agar plates used for the disk diffusion test were 
divided equally into four groups as listed below:
Group 1:1.  14 facultative anaerobically cultured plates 
prepared from oral rinse samples. 
Group 2:2.  14 strict anaerobically cultured plates prepared 
from oral rinse samples.
Group 3:3.  14 plates of pure cultures of S. mutans 
bacteria.
Group 4:4.  14 plates of pure cultures of the fungus C. 
albicans.
The disk diffusion test was performed by adding five ster-
ile, 6mm diameter filter paper disks to each of the 56 BHI 
plates. The disks were evenly distributed on the agar sur-
face. Each disk was saturated with 10µl of a specific CHX 
research
Table 1: Inclusion and exclusion criteria used for recruitment of 
study participants.
Inclusion criteria
Dentate and partially dentate individuals
Adults > 12 years of age
Systemically healthy
Exclusion criteria
Edentulous individuals
Children > 12 years of age
Patients with systemic conditions
Smokers
Individuals who have used antibiotics or immunosuppressive 
drug therapies during the past three months
Persons with active periodontal disease
Persons with active carious lesions
Persons with clinically evident oral candidiasis
Table 2: Description of the Chlorhexidine (CHX) oral rinses used in the study
Codes as per 
disk diffusion test
CHX preparation Active ingredients Inactive ingredients
CHX 1 only CHX 0.2% (laboratory prepared) CHX 0,2% N/A
CHX 2 only CHX 0.12% (laboratory prepared) CHX 0,12% N/A
CHX 3 Corsodyl Mouthwash® (GlaxoSmith-
Kline, Epping, South Africa)
CHX 0.2%, Ethanol 5-6% Unassigned
CHX 4 Curasept ADS® 220 Oral rinse 0.20 % 
CHX (Curaden AG, Krein, Switzerland)
CHX 0.2% ADS, Xylitol, propylene glycol, PEG 40, 
hyd. castor oil, ascorbic acid, Polox-
amer 407, sodium metabisulfite sodium 
citrate, aroma Cl.42090
CHX 5 GUM® Paroex® (Sunstar Europe S.A., 
Etoy, Switzerland)
CHX 0.12%, Cetylpyridinium 
Chloride 0.05%
Aqua, propylene glycol, glycerine, PEG 
40 hydrogenated castor oil, aroma, 
potassium acesulfame, methylparaben, 
propylparaben, C.I. 14720, limonene
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product to be tested and an identifying 
code number assigned. The antibacterial 
effect of each CHX product was quanti-
fied in terms of the formation of inhibition 
zones around the disks, measured 24 
hours following incubation (Figure 1). 
All measurements were carried out using 
a digital calliper, by both the principal 
investigator and by a second clinician, 
who was blinded to the results obtained 
by the former. The diameter of each 
inhibition zone was measured thrice by 
each investigator. If a discrepancy of 
>1mm was found, the measurements 
were repeated. An average of the 
readings of each investigator was taken. 
Data capturing tables were used to 
record the readings.
Data analysis
The mean diameters and standard deviations of the corre-
sponding inhibition zones were calculated and compared 
using the analysis of variance (ANOVA) test. A P value of 
less than 0.05% was considered statistically significant.
RESULTS
A statistically significant difference in the inhibition zones 
was found only in the fungal cultures, as analyzed by 
the ANOVA one-way test. Both Curasept®(0.12% CHX) 
and GUM® Paroex® (0.12% CHX) showed significantly 
smaller inhibition zones (p<0.05) while the only CHX (0,2% 
and 0.12%) as well as Corsodyl® (0,2% CHX), produced 
inhibition zones of comparable sizes (Table 2). When 
the inhibition zones produced by the different cultures 
were compared, all the formulations gave significantly 
larger zones towards S. mutans than did any of the 
other cultures. No significant differences were recorded 
between the zones produced by facultative anaerobic and 
strict anaerobes from the mixed saliva cultures.
When the means of inhibition zones for all CHX formulations 
were considered together, readings could be represented 
as in Figure 2.
DISCUSSION
The results of the study showed no statistically significant 
differences between the antibacterial activities of the three 
mouthrinses evaluated (Corsodyl®, Curasept® and GUM® 
Paroex®), regardless of the CHX concentration or the 
brand of oral rinse tested. The antimicrobial efficacies of 
all CHX formulations were highest against Streptococcus 
mutans, when compared with other cultures, supporting 
the anti-cariogenic role of CHX and its use as an adjuvant 
to mechanical oral hygiene measures.8 
Even though a statistically significant difference was found 
with regard to the antifungal activity between the three 
oral rinses, the inhibition zones produced for C. albicans 
cultures were smaller than those recorded for S. mutans 
cultures. Only CHX preparations and Corsodyl® showed 
a higher antifungal activity compared with Curasept® or 
GUM® Paroex®. This finding is consistent with the litera-
ture where C. albicans displayed a lower susceptibility to 
CHX. This is thought to be due to the greater complexity 
of the fungal cell membranes as compared with that of 
Gram positive bacteria.10 
For both S. mutans and C. albicans, the readings for 
antimicrobial sensitivity across the 14 cultures were 
numerically closer than in both types of cultures prepared 
Figure 1: Typical agar plates showing S. mutans and C. albicans growth 
colonies (above and below respectively). BHI agar plate Number 5 (of 14) 
showing inhibition zones around different CHX preparations. 
Numbers on filter papers denotes the following: 1: CHX1 (only CHX 0.2%), 
2: CHX2 (only CHX 0.12%), 3: CHX3 (Corsodyl® - 0.2% CHX), 4: CHX4 
(Curasept® - O.12%CHX) and 5: CHX5 (GUM® Paroex® - 0.12% CHX)
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Figure 2: Graph comparing mean inhibition zones for chlorhexidene (CHX) preparations.
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from participants’ oral rinses. Such variability reflects 
the qualitative differences in oral microbial flora between 
individuals.
Only CHX (0.2%) exhibited the highest antimicrobial ef-
ficacy followed by Corsodyl® (containing 5% alcohol) and 
then Curasept®.The latter has a similar CHX concentra-
tion but is alcohol free. Alcohol acts as an emulsifier, as a 
solvent for active ingredients, as a preservative and as an 
antiseptic.13 Perhaps the alcohol in Corsodyl® acted as a 
diluent of CHX and the additive in Curasept® (anti-discol-
ouration systems) could have decreased the antimicrobial 
efficacy of CHX4, due to interaction with the strong posi-
tive charge of the CHX molecule.9
Even though GUM® Paroex® contains 0.05% CPC, it was 
surpassed in antimicrobial efficacy by pure CHX 0.12%. 
This could probably also be attributed to the aforemen-
tioned chemical interactions between CHX and addi-
tives, thereby reducing its efficacy. Nevertheless, GUM® 
Paroex® had similar antimicrobial efficacy as Curasept® 
(0.2% CHX), and this was probably due to the fact that it 
contained 0.05% CPC. 
CONCLUSION
The results of the study show that both the pure (0.12% 
and 0.2%) CHX preparations as well as the  0.2% CHX 
preparation containing alcohol (Corsodyl®) have more po-
tent antifungal properties against C. albicans than does 
alcohol-free 0.12% CHX preparations such as Curasept® 
and GUM® Paroex®. CHX preparations are effective 
against most classes of oral microflora and is well chosen 
as an adjunct to plaque removal.
Ethical approval for the study was obtained from the UWC Dental 
Faculty.
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Table 3: Group means and Standard Deviations for inhibition zones (in cm)
n=14 Only CHX 0.2%
Only CHX 
0.12%
Corsodyl®
0,2%CHX
Curasept®
0.12% CHX
GUM® Paroex®
0.12% CHX
Streptococcus mutans 2.48± 0.37 2.31± 0.47 2.39± 0.44 2.15± 0.39 2.10± 0.32
Candida albicans 1.30± 0.09 1.25± 0.11 1.29± 0.11 1.06± 0.06 1.05± 0.10
Facultative anaerobes 1.31± 0.36 1.28± 0.36 1.23± 0.34 1.20± 0.34 1.19± 0.34
Strict anaerobes 1.34± 0.29 1.21± 0.29 1.29± 0.29 1.17± 0.27 1.13± 0.40
ANOVA p value ≤ 0.0001
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